S. Gade

发表

Graph based fusion of high-dimensional gene- and microRNA expression data

S. Gade, 2013 .

Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer.

V. Beneš, C. von Kalle, R. Eils, 2013, Cancer cell.

Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry

G. Drewes, W. Huber, M. Bantscheff, 2015, Nature Protocols.

PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (her2) therapy in primary HER2-overexpressing breast cancer.

Carsten Denkert, Peter A Fasching, Andreas Schneeweiss, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MYCN-mediated overexpression of mitotic spindle regulatory genes and loss of p53-p21 function jointly support the survival of tetraploid neuroblastoma cells.

Nathalie Harder, Karl Rohr, Rainer König, 2013, Cancer letters.

Expression of secreted protein acidic and rich in cysteine (SPARC) in breast cancer and response to neoadjuvant chemotherapy.

P. Fasching, C. Denkert, H. Tesch, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Increasing the sensitivity of reverse phase protein arrays by antibody-mediated signal amplification

C. Schmidt, S. Wiemann, T. Beißbarth, 2010, Proteome Science.

BIOINFORMATICS Integration of pathway knowledge into a reweighted recursive feature elimination approach for risk stratiﬁcation of cancer patients

T. Beißbarth, H. Fröhlich, M. Fälth, 2010 .

Abstract S3-1: Neoadjuvant Chemotherapy in the very young 35 years of age or younger

A. Schneeweiss, C. Denkert, S. Loibl, 2012 .

Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trials

A. Schneeweiss, P. Neven, C. Denkert, 2015, Breast Cancer Research and Treatment.

Multiplexed Proteome Dynamics Profiling Reveals Mechanisms Controlling Protein Homeostasis

P. Grandi, M. Bantscheff, M. Savitski, 2018, Cell.

Abstract S4-06: PIK3CA mutation predicts resistance to anti-HER2/chemotherapy in primary HER2-positive/hormone-receptor-positive breast cancer – Prospective analysis of 737 participants of the GeparSixto and GeparQuinto studies

M. Rezai, P. Fasching, A. Schneeweiss, 2013 .

Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancers.

Carsten Denkert, Stephan Wienert, Frederick Klauschen, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial

P. Fasching, S. Loibl, K. Pantel, 2014, Breast Cancer Research and Treatment.

TGF-b signaling

Tim Beißbarth, Holger Sültmann, Ulrike Korf, 2022 .

Deciphering clonality in aneuploid breast tumors using SNP array and sequencing data

T. Speed, C. Sotiriou, P. Neven, 2014, Genome Biology.

Graph based fusion of miRNA and mRNA expression data improves clinical outcome prediction in prostate cancer

Tim Beißbarth, Holger Sültmann, Harald Binder, 2011, BMC Bioinformatics.

Integration of pathway knowledge into a reweighted recursive feature elimination approach for risk stratification of cancer patients

Holger Fröhlich, Tim Beißbarth, Holger Sültmann, 2010, Bioinform..

RPPanalyzer: Analysis of reverse-phase protein array data

Heiko A. Mannsperger, Tim Beißbarth, Ulrike Korf, 2010, Bioinform..